		Transcriptional Regulation Co-Immunoprecipitation DNA Repair Luciferase Reporter Assay Nuclear Receptor ELISAs Supershift & Gelshift Assays Transcription Factor DNA-binding ELISAs Epigenetics & Chromatin Chromatin Assembly Chromatin IP DNA Damage – Phospho-H2AX DNA Methylation Histone Acetyltransferase Activity (HAT) Histone Deacetylase Activity (HDAC) Histone Purification Protein Modification GTPase Activation Assay Kinase Assay Substrate Mitosis Assays Nitric Oxide Quantitation Phospho-Protein Detection Sandwich ELISAs SUMOylation Antibodies, Extracts & Proteins Antibodies Cell Extracts Recombinant Proteins Fluorescence & Labeling Albumin Quantification Cell Viability Assay Fluorescent Dyes & Labeling Immunofluorescence Live Cell Membrane Staining Mitosis Determination Protein and Extract Quantification Protein Labeling & Translocation Sample Preparation Fluorescent Dye Labeling Mitochondrial Separation mRNA Isolation Normalization Nuclear & Cytoplasmic Extraction Protein & Extract Quantification Transfection & Expression Competent E. coli Gene Silencing Protein Transfection Staining Reagents Bioinformatics & Text Mining TimeLogic® Biocomputing Solutions AKS 2

Press Room

Translational Genomics Research Institute (TGen) Licenses AKS2 from Active Motif

2007-02-09

Active Motif today announced that Translational Genomics Research Institute (TGen), based in Phoenix, Arizona, has licensed its unique knowledge mining software, AKS² (almaKnowledgeServer™). TGen will use this software to facilitate the interrogation of genomic-profiling data such as high-throughput siRNA screening.

"AKS² will help us integrate prior knowledge located in the literature in a rapid and efficient manner. We will use AKS² as an integral part of the knowledge mining activities that support the pharmacogenomic-based research activities within TGen," said Dr. Jeff Kiefer, Head of the Knowledge Mining Lab in TGen's Pharmaceutical Genomics Division.

Joseph Fernandez, CEO of Active Motif, commented, "Our customers continue to see the value of biocomputing and knowledge mining tools, and they understand how using these technologies to analyze their data more thoroughly will greatly enhance their research efforts. I am pleased that an organization as prestigious as TGen has selected Active Motif to be an integral part of their pharmacogenomic-based research."

BROWSE BY: